About Hexal
Hexal is a Healthcare company based in Holzkirchen (Germany) founded in 1986, and was acquired by Novartis in February 2005. OTC pharmaceutical products are developed by Hexal using active ingredients. Its chief executive, as recorded, is Stephan Eder. Its website hexal.de draws about 45 thousand monthly visits. Hexal offers products and services including Potatoes and Grain Marketing. Its focus areas include Traditional Pharmaceuticals and Generics. Its legal entity is Maine Potato Growers, Inc.
Company details
Hexal was founded in 1986 in Holzkirchen, Germany, as a developer of over-the-counter medications. Active ingredients are utilized in formulations for brands including ACC Acut, Gingium, and OMEP. Operations focus on pharmaceutical production within the healthcare sector. The company operates as part of the SandozNovartis Group, with activities centered in Germany.
Products & Services of Hexal
Hexal offers a comprehensive portfolio of products and services, including Potatoes and Grain Marketing.
Potatoes are farmed and sold for food and industrial uses within the operations of Maine Potato Growers.
Grains are promoted and distributed from farms through the services offered by Maine Potato Growers.
Funding Insights of Hexal
- Total Rounds 1
- Last Round Grant — $294,222
- First Round $294,222
(Oct 2017)
All 1 funding rounds of Hexal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2017 | $294,222 | Grant | – | – | – |
1 investors in total: 1 institutional.
Investors in Hexal
Hexal has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novartis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
R&D focused on manufacturing of drugs for multiple therapeutic areas | 1996 | novartis.com | Basel, Switzerland |
Investor details for Hexal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Hexal
1 people are tracked at Hexal (1 in leadership).
| Name | Role | Group |
|---|---|---|
Stephan Eder | CEO | Leadership |
Complete people profiles for Hexal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Hexal
3 dated milestones of Hexal across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Hexal is founded.
- Exit Acquired by Novartis.
- Funding First funding round of $294K.
Web traffic of Hexal
The website of Hexal (hexal.de) receives about 45.3K visits a month.
- Monthly visits45.3K
▲ 88.9% vs previous month
Websites whose visitors overlap most with Hexal. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
allergiecheck.de | allergiecheck.de | 100% | #718,140 | – | |
stada.de | stada.de | 99% | #622,873 | – | |
pollenstiftung.de | pollenstiftung.de | 90% | #4,121,217 | – | |
| allergieratgeber.de | 89% | #2,861,876 | View details | ||
sl-preise.ch | sl-preise.ch | 85% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Hexal
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hexal
Complete news archive for Hexal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hexal
Hexal was founded in 1986 and raised its 1st funding round 31 years after it was founded.
Hexal is headquartered in Holzkirchen, Germany. It is registered at Holzkirchen, Bavaria, Germany.
Stephan Eder is the CEO of Hexal, as recorded in our data.
Hexal was founded in 1986 in Holzkirchen, Germany, as a developer of over-the-counter medications. Active ingredients are utilized in formulations for brands including ACC Acut, Gingium, and OMEP. Operations focus on pharmaceutical production within the healthcare sector. The company operates as part of the SandozNovartis Group, with activities centered in Germany.
Hexal offers Potatoes and Grain Marketing.
Hexal has 1 investor. Key investors include Novartis.
Hexal operates through Maine Potato Growers, Inc.
Yes. Hexal was acquired by Novartis in February 2005.